Inflammation

Nordic touts PRO-C6 biomarker for heart failure clinical trials
In collaboration with Bristol Myers Squibb and the University of Pennsylvania, researchers combined analyses of six independent cohorts of HFpEF patients from around the globe, which are being evaluated with the PRO-C6 biomarker.
September 13, 2022
2022 09 14 21 40 5599 Heart Pulmonary Trunk 400
Pharos Capital sells TechLab to SSI Diagnostica
TechLab produces tests for infectious diseases, intestinal inflammation, and parasites, as well as gastrointestinal conditions such as inflammatory bowel disease, irritable bowel syndrome, and Escherichia coli infection. It also offers a test for Clostridioides difficile called Quik Chek, according to Pharos Capital.
August 21, 2022
2022 04 22 17 54 4420 Business Handshake Man 400
Bruker launches long-COVID assessment test
The test, PhenoRiskPacs RuO, uses a multiplexed combination of biomarkers discovered at the Australian National Phenome Center at Murdoch University.
July 7, 2022
2022 01 26 23 43 5876 Niaid Sars Co V 2 Patient 400
Roche, Nordic Bioscience partner on tissue disease markers
According to Nordic, the extracellular matrix markers it develops are essential for chronic diseases involving tissue fibrosis and inflammation, and the collaboration with Roche will facilitate better clinical decisions in drug development and patient selection for precision medicine.
June 15, 2022
2022 06 16 19 33 6973 Fat Tissue Adipocytes 400
Quest introduces personal health panel
Quest's Comprehensive Health Profile is like a credit score for an individual's health, Quest said. The panel combines many of the tests and biometric screenings that a physician would typically order as part of an annual physical, such as a complete blood count, comprehensive metabolic panel, urinalysis, cardiovascular and diabetes risk assessment, plus others, such as inflammation, Quest said.
January 19, 2022
2020 04 02 20 02 8495 Quest Diagnostics 400
Immunexpress sepsis test gets FDA 510(k) clearance
SeptiCyte Rapid uses reverse transcription polymerase chain reaction to quantify directly from blood the relative expression of genes involved in a patient's immune response, the company said.
November 29, 2021
2019 02 13 19 24 5396 Fda Logo V2 400
Allara launches new hormone test for women
The test measures several factors, including anti-müllerian hormone (AMH), testosterone, and thyroid levels, to determine potential hormonal imbalances and conditions, including polycystic ovarian syndrome. Additionally, the test analyzes metabolic factors, including insulin resistance, cholesterol levels, vitamin deficiencies, and inflammation levels.
November 2, 2021
2019 07 26 20 46 7792 Lab Blood Woman 400
Inflammatory biomarkers help quickly size up COVID-19 patients
Poster studies are available on demand at the virtual meeting, which runs from December 13-17.
December 16, 2020
2020 12 15 23 56 5856 Gentian Gcal 400
CRP changes are a 'very powerful' tool for COVID-19 triage
As a marker of inflammation, CRP testing has been of high interest for assessment of COVID-19, along with other lab measures. However, the new study focused on the change in CRP in the first few days of hospital admission as opposed to a single value when patients first arrived.
November 8, 2020
2020 11 09 18 07 5733 Doctor Nurse Ppe 400
Blood test score helps predict COVID-19 severity
The Dublin-Boston score is intended to help physicians identify COVID-19 patients who may benefit from therapies such as steroids and admission to intensive care. It predicts the severity of the illness on day seven of infection, after measuring the patient's blood for four days, by tracking levels of interleukin-6 (IL-6) and IL-10, molecules that control the body's immune system and inflammation. Levels of both these molecules are altered in patients with severe COVID-19.
October 14, 2020
2020 05 15 23 50 8470 2020 05 14 Bloodtest 400
Blood test could identify risk of psychotic disorders
The findings could help clinicians better assess and treat patients, wrote a team led by David Cotter, PhD, of the Royal College of Surgeons in Ireland (RCSI) University of Medicine and Health Sciences in Dublin, Ireland.
August 27, 2020
2020 05 15 23 50 8470 2020 05 14 Bloodtest 400
Biomarkers to determine COVID-19 odds: GW researchers
A research team led by Dr. Shant Ayanian, an assistant professor of medicine at the GW School of Medicine & Health Sciences, evaluated 299 patients diagnosed with COVID-19 and admitted to GW Hospital between March 12 and May 9 (Future Medicine, July 17, 2020). More than two-thirds (200) of the patients had all five biomarkers evaluated: interleukin-6 (IL-6), D-dimer, C-reactive protein (CRP), lactate dehydrogenase (LDH), and ferritin. Elevated levels of the biomarkers were associated with inflammation and bleeding disorder, showing an independent increased risk for intensive care unit admission, invasive ventilatory support, and death.
August 6, 2020
2019 05 13 16 12 9218 Lab Blood Woman2 400
Page 1 of 4
Next Page